United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 82,586 | 68,362 | 122,655 | 24,373 | 200,935 |
| Marketable Securities | 200 | 200 | N/A | 31,677 | 14,484 |
| Receivables | 15,808 | 10,693 | 9,659 | 4,224 | 1,534 |
| Inventories | 8,014 | 8,116 | 7,164 | 6,025 | 2,897 |
| Other current assets | 654 | 476 | 1,145 | 1,787 | 1,193 |
| TOTAL | $110,492 | $89,721 | $141,857 | $69,003 | $222,120 |
| Non-Current Assets | |||||
| PPE Net | 17,799 | 15,225 | 9,120 | 6,403 | 5,939 |
| Investments And Advances | 63,798 | 55,996 | 16,388 | 120,591 | 4,349 |
| Intangibles | 13,432 | 13,911 | 14,466 | 15,365 | 0 |
| Other Non-Current Assets | 1,637 | 4,649 | 2,735 | 759 | 18,237 |
| TOTAL | $96,666 | $89,781 | $42,709 | $143,118 | $28,525 |
| Total Assets | $207,158 | $179,502 | $184,566 | $212,121 | $250,645 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 16 | 773 | 111 | 102 | 71 |
| Accounts payable and accrued liabilities | 6,127 | 4,326 | 2,988 | 6,667 | 5,952 |
| Accrued Expenses | 7,689 | 5,459 | 4,451 | 3,454 | 4,523 |
| Other current liabilities | N/A | 59 | 51 | 75 | N/A |
| TOTAL | $13,864 | $10,618 | $9,307 | $10,798 | $11,492 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10 | 25 | 1,767 | 1,836 | 1,836 |
| Other Non-Current Liabilities | 1,648 | 1,094 | 1,834 | 3,088 | 2,579 |
| TOTAL | $1,658 | $1,119 | $3,601 | $4,924 | $4,415 |
| Total Liabilities | $15,522 | $11,737 | $12,908 | $15,722 | $15,907 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,986 | 42,665 | 41,848 | 40,450 | N/A |
| Common Shares | 229 | 218 | 215 | 208 | 207 |
| Retained earnings | -180,341 | -195,790 | -185,821 | -162,170 | -124,882 |
| Other shareholders' equity | 2,803 | 1,800 | 134 | 126 | -72 |
| TOTAL | $191,636 | $167,765 | $171,658 | $196,399 | $234,738 |
| Total Liabilities And Equity | $207,158 | $179,502 | $184,566 | $212,121 | $250,645 |